Sign in
Taking people in United StatesNo phase

Pain and Smoking Study 2.0: A Randomized Clinical Trial of Smoking Cessation Among Veterans With Chronic Pain

Key facts

Who runs it
VA Office of Research and Development
Where
West Haven, United StatesSee the site
Trial code
Status
Recruiting
People taking part
220 people, planned
Started
21 Sept 2026
Expected to end
31 May 2028
Type of study
Interventional, 2 groups
Treatments tested
  • PASS2
  • Treatment as Usual
Record updated
29 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • being an enrolled Veteran at VACHS
  • current tobacco use
  • willingness to make a quit attempt
  • significant chronic pain defined as >/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days

Who cannot take part

  • enrollment in concurrent research study that might affect main outcomes of this study
  • active diagnosis of dementia or psychosis in medical record
  • terminal illness
  • severely impaired hearing or speech
  • lack of telephone access
  • non-English speaking
  • pregnancy
  • provider advising against exercise
  • planned surgeries
  • clinically significant depressive symptoms (>10 PHQ-9)

Where in United States

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CTWest Haven, United StatesContact: Lori A Bastian, MD MPHTaking people

About the trial

What the trial wants to find out

PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use nightly surveys to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.

The 2 groups in the trial

  • PASS2Treatment being tested

    An intervention that includes a proactive telehealth intervention combining evidence-based smoking cessation counseling augmented with behavioral approaches for coping with pain, and nightly surveys. Veterans in PASS2 will also be offered 12-weeks of pharmacotherapy (e.g., NRT patches and one of two rescue methods such as nicotine lozenge or gum or varenicline) via telemedicine consult. The NRT dose and delivery route will be tailored to the number of cigarettes smoked per day (using an established protocol).

  • Treatment as UsualOther group

    Treatment as usual includes referral to the local smoking cessation clinic where Veterans may select a virtual individual or group based cognitive behavioral smoking cessation program with a trained psychology intern, postdoctoral fellow or staff psychologist. In conjunction, Veterans are encouraged but not required, by clinic staff, to connect with the VA Quitline and the VA's Annie text-messaging service to support their quit. Veterans are strongly encouraged to consider pharmacotherapy (e.g., NRT patches and one of two rescue methods such as nicotine lozenge or gum or varenicline). The NRT dose and delivery route will be tailored to the number of cigarettes smoked per day (using an established protocol - interested Veterans will be offered a telemedicine consult for this service

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Enhancing an Intervention for Smokers With Chronic Pain Using IVR: A Randomized Clinical Trial of Smoking Cessation Counseling for Veterans
Record updated
29 September 2026